Aishwarya Healthcare
Ofloxacin (200mg) + Ornidazole (500mg)
Oflonir OZ 200mg/500mg Tablet is a combination of two antibiotics used to treat bacterial and parasitic infections.
Tablet
Oflonir OZ 200mg/500mg Tablet is a combination of two antibiotics: Ofloxacin and Ornidazole. It is used in the treatment of bacterial and parasitic infections. It effectively treats a wide range of bacterial infections that may occur in the teeth, lungs, gastrointestinal infections, urinary and genital tract.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Oflonir OZ 200mg/500mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Oflonir OZ 200mg/500mg Tablet.
Information regarding the use of Oflonir OZ 200mg/500mg Tablet during breastfeeding is not available. Please consult your doctor.
Oflonir OZ 200mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Oflonir OZ 200mg/500mg Tablet is a combination of two antibiotics: Ofloxacin and Ornidazole. Ofloxacin works by preventing the bacterial cells from dividing and repairing, thereby killing the bacteria. Ornidazole kills parasites and anaerobic bacteria that cause infections by damaging their DNA. Together, they treat your infection effectively.
You have been prescribed Oflonir OZ 200mg/500mg Tablet for the treatment of various bacterial and parasitic infections. It may cause dizziness and sleepiness. Do not drive or do anything that requires mental focus until you know how it affects you. Avoid consuming alcohol when taking Oflonir OZ 200mg/500mg Tablet as it may irritate your stomach and also cause excessive drowsiness. Inform your doctor if you are pregnant or planning to conceive or breastfeeding.
Oflonir OZ 200mg/500mg Tablet is a combination medication that contains two active ingredients: Ofloxacin and Ornidazole. These antibiotics work together to eliminate harmful microorganisms causing infections, effectively treating your condition.
For most patients, Oflonir OZ 200mg/500mg Tablet is generally considered safe. However, some individuals might experience common side effects such as nausea, vomiting, stomach pain, dizziness, headache, dry mouth, and heartburn. In rare cases, other side effects may occur. If you're experiencing persistent or severe issues, consult your doctor for further guidance.
Oflonir OZ 200mg/500mg Tablet is not suitable for patients with known allergies to Ofloxacin or Ornidazole, or individuals who have experienced adverse reactions to other medications in the quinolone and nitroimidazole groups.
No, taking more than the prescribed dose can increase the risk of side effects. If you experience increased symptoms not alleviated by the recommended doses, consult your doctor for re-evaluation and guidance.
Inform your doctor if you do not feel better or experience worsening symptoms after completing the full treatment course. This will help your healthcare provider assess and address any potential issues.
No, it is essential to complete the full treatment course as prescribed by your doctor. Your symptoms may improve before the infection is fully cleared.
Take Oflonir OZ 200mg/500mg Tablet as soon as you remember it, but do not take an additional dose to make up for a missed one. If it's almost time for your next scheduled dose, skip the missed one and continue with the regular dosing schedule.
It is recommended to avoid consuming alcohol as it may exacerbate dizziness and sleepiness caused by the medication. Consult your doctor if you're unsure about the effects of alcohol with this medicine.
Keep the medication in its original container, tightly closed. Store it according to the instructions on the packaging or label. Dispose of unused medicine responsibly, ensuring it is not accessible to children, pets, or other individuals.